Page 83 - 《中国药房》2024年13期
P. 83

diorenal syndrome[J]. Aging,2021,13(3):4215-4241.   models  of  hyperthyroidism[J].  Guangdong  Med  J,2020,
          [ 7 ]  WANG Y Y,LIU Y Y,LI J,et al. Gualou xiebai decoction   41(24):2526-2530.
              ameliorates cardiorenal syndrome type Ⅱ by regulation of   [14]  吴英智,李志梁,赖俊,等. 白术内酯Ⅰ对心肾综合征大
              PI3K/Akt/NF-κB signaling pathway[J]. Phytomedicine,  鼠心肾功能的影响及机制[J]. 现代中西医结合杂志,
              2024,123:155172.                                    2023,32(20):2788-2797.
          [ 8 ]  SITI H N,JALIL J,ASMADI A Y,et al. Effects of querce‐  WU Y Z,LI Z L,LAI J,et al. AtractylenolideⅠ protects
              tin on cardiac function in pressure overload and postische-  cardiac  and  renal  function  of  rats  with  cardiorenal  syn‐
              mic  cardiac  injury  in  rodents:a  systematic  review  and   drome via suppressing fibrosis synthesis[J]. Mod J Integr
              meta-analysis[J].  Cardiovasc  Drugs  Ther,2022,36(1):  Tradit Chin West Med,2023,32(20):2788-2797.
              15-29.                                         [15]  GALLO G,LANZA O,SAVOIA C. New insight in cardio‐
          [ 9 ]  FENG Q,YANG Y,QIAO Y J,et al. Quercetin amelio‐  renal syndrome:from biomarkers to therapy[J]. Int J Mol
              rates  diabetic  kidney  injury  by  inhibiting  ferroptosis  via   Sci,2023,24(6):5089.
              activating  Nrf2/HO-1  signaling  pathway[J].  Am  J  Chin   [16]  GEORGOPOULOU T,PETRAKIS I,DERMITZAKI K,
              Med,2023,51(4):997-1018.                            et al. Cardiorenal syndrome:challenges in everyday clini‐
          [10]  BAGHERI A,RADMAN G,ARIA N,et al. The effects of   cal practice and key points towards a better management
              quercetin on apoptosis and antioxidant activity in a renal   [J]. J Clin Med,2023,12(12):4121.
              ischemia/reperfusion  injury  animal  model[J].  Drug  Res,  [17]  LUO  M,LIU  Z  Y,HU  Z  R,et  al.  Quercetin  improves
              2023,73(5):255-262.                                 contrast-induced acute kidney injury through the HIF-1α/
          [11]  王时光,刘攀,任超,等. 黄芪甲苷对心肾综合征大鼠的                        lncRNA NEAT1/HMGB1 pathway[J]. Pharm Biol,2022,
              肾功能保护作用研究[J]. 中国临床药理学杂志,2023,39                     60(1):889-898.
              (3):363-367.                                   [18]  POVEDA J,VÁZQUEZ-SÁNCHEZ S,SANZ A B,et al.
              WANG  S  G,LIU  P,REN  C,et  al.  Protective  effect  of       TWEAK-Fn14 as a common pathway in the heart and the
              astragaloside Ⅳ on renal function in rats with cardiorenal   kidneys  in  cardiorenal  syndrome[J].  J  Pathol,2021,254
              syndrome[J].  Chin  J  Clin  Pharmacol,2023,39(3):  (1):5-19.
              363-367.                                       [19]  DU L,ZHANG J R,ZHANG X Y,et al. Oxypeucedanin
          [12]  JIANG C J,LI D,CHEN L,et al. Quercetin ameliorated   relieves  LPS-induced  acute  lung  injury  by  inhibiting  the
              cardiac injury via reducing inflammatory actions and the   inflammation and maintaining the integrity of the lung air-
              glycerophospholipid  metabolism  dysregulation  in  a  dia‐  blood barrier[J]. Aging,2022,14(16):6626-6641.
              betic cardiomyopathy mouse model[J]. Food Funct,2022,  [20]  TSUKAMOTO S,WAKUI H,UEHARA T,et al. Combi‐
              13(14):7847-7856.                                   nation  of  sacubitril/valsartan  and  blockade  of  the  PI3K
          [13]  王万民,田涛 . 甲状腺功能亢进症模型大鼠心肌细胞                         pathway enhanced kidney protection in a mouse model of
              PI3K/Akt通路与胰岛素抵抗的关系[J]. 广东医学,2020,                  cardiorenal syndrome[J]. Eur Heart J Open,2023,3(6):
              41(24):2526-2530.                                   oead098.
              WANG W M,TIAN T. The correlation between PI3K/Akt             (收稿日期:2024-01-17  修回日期:2024-05-19)
              pathway  and  insulin  resistance  in  cardiomyocytes  of  rat                      (编辑:唐晓莲)




























          中国药房  2024年第35卷第13期                                              China Pharmacy  2024 Vol. 35  No. 13    · 1617 ·
   78   79   80   81   82   83   84   85   86   87   88